Multiple-unit tablet of probiotic bacteria for improved storage stability, acid tolerability, and in vivo intestinal protective effect

References

• KaurIPChopraKSainiAProbiotics: potential pharmaceutical applicationsEur J Pharm Sci2002151911803126
   PubMed Web of Science ®Google Scholar
• SandersMEConsiderations for use of probiotic bacteria to modulate human healthJ Nutr20001302S Suppl384S390S10721912
   PubMedGoogle Scholar
• GratzSWMykkanenHEl-NezamiHSProbiotics and gut health: a special focus on liver diseasesWorld J Gastroenterol20101640341020101763
   PubMed Web of Science ®Google Scholar
• GismondoMRDragoLLombardiAReview of probiotics available to modify gastrointestinal floraInt J Antimicrob Agents19991228729210493604
   PubMed Web of Science ®Google Scholar
• DunneCAdaptation of bacteria to the intestinal niche: probiotics and gut disorderInflamm Bowel Dis2001713614511383587
   PubMed Web of Science ®Google Scholar
• VinderolaCGBailoNReinheimerJASurvival of probiotic microflora in Argentinian yoghurts during refrigerated storageFood Res Int20003397102
   Web of Science ®Google Scholar
• KailasapathyKChinJSurvival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacte-rium sppImmunol Cell Biol200078808810651933
   PubMed Web of Science ®Google Scholar
• BerradaNLemelandJFLarocheGThouvenotPPiaiaMBifidobac-terium from fermented milks: survival during gastric transitJ Dairy Sci1991744094132045548
   PubMed Web of Science ®Google Scholar
• BouhnikYPochartPMarteauPArletGGoderelIRambaudJCFaecal recovery in humans of viable Bifidobacterium sp. ingested in fermented milkGastroenterology19921028758781537524
   PubMed Web of Science ®Google Scholar
• VidhyalakshmiRBhakyarajRSubhasreeRSEncapsulation “the future of probiotics” – a reviewAdv Biol Res2009396103
   Google Scholar
• ParkHJLeeGYJunJHFormulation and in vivo evaluation of probiotics-encapsulated pellets with hydroxypropyl methylcellulose acetate succinate (HPMCAS)Carbohydr Polym201613669269926572402
   PubMed Web of Science ®Google Scholar
• StadlerMViernsteinHOptimization of formulation containing viable lactic acid bacteriaInt J Pharm200325611712212695017
   PubMed Web of Science ®Google Scholar
• ZeeshanFPehKKTanYTExploring the potential of a highly compressible microcrystalline cellulose as novel tableting excipient in the compaction of extended-release coated pellets containing an extremely water-soluble model drugAAPS PharmSciTech20091085085719554454
   PubMed Web of Science ®Google Scholar
• ChanESZhangZEncapsulation of probiotic bacteria Lactobacillus acidophilus by direct compressionFood Bioprod Process2002807882
   Web of Science ®Google Scholar
• PoulinJFCaillardRSubiradeMβ-Lactoglobulin tablets as a suitable vehicle for protection and intestinal delivery of probiotic bacteriaInt J Pharm2011405475421129464
   PubMedGoogle Scholar
• TorradoJJAugsburgerLLEffect of different excipients on the tableting of coated particlesInt J Pharm1994106149155
   Web of Science ®Google Scholar
• VergoteGJKiekensFVervaetCRemonJPWax beads as cushioning agents during the compression of coated diltiazem pelletsEur J Pharm Sci20021714515112393142
   PubMed Web of Science ®Google Scholar
• ObaraSMaruyamaNNishiyamaYKokuboHDry coating: an innovative enteric coating method using a cellulose derivativeEur J Pharm Biopharm199947515910234527
   PubMed Web of Science ®Google Scholar
• WindingABinnerupSJSørensenJViability of indigenous soil bacteria assayed by respiratory activity and growthAppl Environ Microbiol1994602869287516349355
   PubMed Web of Science ®Google Scholar
• HwangRCPeckGRA systematic evaluation of the compression and tablet characteristics of various types of microcrystalline cellulosePharm Technol200124112132
   Google Scholar
• PatelSKaushalAMBansalAKCompression physics in the formulation development of tabletsCrit Rev Ther Drug Carrier Syst20062316516749898
   PubMed Web of Science ®Google Scholar
• BolhuisGKArmstrongNAExcipients for direct compaction – an updatePharm Dev Technol20061111112416544915
   PubMed Web of Science ®Google Scholar
• Al-IbraheemiaZAMAnuaraMSTaipaFSAminbMCITahircSMMahdiaABDeformation and mechanical characteristics of compacted binary mixtures of plastic (microcrystalline Cellulose), elastic (sodium starch glycolate), and brittle (lactose monohydrate) pharmaceutical excipientsParticul Sci Technol201331561567
   Web of Science ®Google Scholar
• RubinsteinMHTabletsAultonMEAultonMEPharmaceutics: The Science of Dosage form DesignLondonChurchill Livingstone1988304321
   Google Scholar
• AsanoTTsubukuSSugawaraSChanges in volume and compression energy upon compression of calcium silicate tabletsDrug Dev Ind Pharm199723679685
   Web of Science ®Google Scholar
• VervaetCYliruusiJDe SmedtSMehuysMTable Formulation of Porous Silicon Microparticles for Improved Dissolution of Poorly Soluble Drug MaterialsGhentGhent University2009
   Google Scholar
• KlayraungSViernsteinHOkonogiSDevelopment of tablets containing probiotics: effects of formulation and processing parameters on bacterial viabilityInt J Pharm2009370546019059323
   PubMed Web of Science ®Google Scholar
• RossRPDesmondCFitzgeraldGFStantonCOvercoming the technological hurdles in the development of probiotic foodsJ Appl Microbiol2005981410141715916653
   PubMed Web of Science ®Google Scholar
• ZaikaLLSpices and herbs: their antimicrobial activity and its determinationJ Food Saf1998997118
   Google Scholar
• RoyPAbdulsalamFIPandeyDKBhattacharjeeAEruvaramNRMalikTEvaluation of antioxidant, antibacterial, and antidiabetic potential of two traditional medicinal plants of India: Swertia cordata and Swertia chirayitaPharmacognosy Res20157S57S6226109789
   PubMedGoogle Scholar
• MullerCMazelVDaussetCStudy of the Lactobacillus rham-nosus Lcr35® properties after compression and proposition of a model to predict tablet stabilityEur J Pharm Biopharm20148878779425128853
   PubMed Web of Science ®Google Scholar
• OuwehandACAntiallergic effects of probioticsJ Nutr2007137794797
   PubMed Web of Science ®Google Scholar
• Al-AttasOSAl-DaghriNMAl-RubeaanKChanges in endo-toxin levels in T2DM subjects on anti-diabetic therapiesCardiovasc Diabetol200982019368716
   PubMed Web of Science ®Google Scholar
• MillerMMcTernanPHarteAEthnic and sex differences in circulating endotoxin levels: a novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic populationAtherosclerosis200920349450218672240
   PubMed Web of Science ®Google Scholar
• HarteALda SilvaNFCreelySJElevated endotoxin levels in non-alcoholic fatty liver diseaseJ Inflamm201030715
   Google Scholar
• UraoMFujimotoTLaneGJSeoGMiyanoTDoes probiotics administration decrease serum endotoxin levels in infants?J Pediatr Surg19993427327610052803
   PubMed Web of Science ®Google Scholar
• ChangBSangLWangYTongJZhangDWangBThe protective effect of VSL#3 on intestinal permeability in a rat model of alcoholic intestinal injuryBMC Gastroenterol20131315124138544
   PubMed Web of Science ®Google Scholar
• YonejimaYMoriYUshidaKEffect of a tablet containing probiotic bacteria and stomachic herbs on human fecal microbiotaBiosci Microflora2008278792
   Google Scholar
• CommaneDMShorttCTSilviSCresciAHughesRMRowlandIREffects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colonNutr Cancer20055110210915749636
   PubMed Web of Science ®Google Scholar
• IsolauriESalminenSProbiotics, gut inflammation and barrier functionGastroenterol Clin North Am20053443745016084306
   PubMed Web of Science ®Google Scholar
• Caballero-FrancoCKellerKDe SimoneCChadeeKThe VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cellsAm J Physiol Gastrointest Liver Physiol2007292315322
   PubMed Web of Science ®Google Scholar